SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 25, 1999
BIOJECT MEDICAL TECHNOLOGIES INC.
-------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Oregon
-------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-15360 93-1099680
- --------------------------------- -----------------------------------
(Commission File Number) (IRS Employer Identification No.)
7620 S.W. Bridgeport Road
Portland, Oregon 97224
- ----------------------------------------- -------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (503) 639-7221
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Page 1 of 8 Pages
Exhibit Index on Page 4
- more -
Item 5. Other Events
The press release attached as Exhibit 99.1 is incorporated by reference herein.
Item 7. Exhibits
99.1 Press release dated June 25, 1999
- more -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOJECT MEDICAL TECHNOLOGIES INC.
Date: June 25, 1999 By /s/ Michael A. Temple
--------------------------------------
Michael A. Temple
Vice President, Chief Financial
Officer and Secretary
- more -
Exhibit Index
Exhibit
Number Exhibit Page
- ------ ------- ----
99.1 Press release dated June 25, 1999
- more -